NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/14/2022
Back to search
Official data from USPTO
SCRIPT PARTNER PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SCRIPT PARTNER PHARMACY
ST13
US500000090169133Class
35
Filing
90169133
Registration
6762585
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
06/14/2022
Trademark type
Word
Nice classes
35
Filing date
09/09/2020
Registration date
06/14/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2022
Last transaction
06/14/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
03/08/2021
First use in commerce
03/08/2021
Drawing code
4
Owner type
03
Owner location
New York, NY, US
Examiner
MORRIS, KRISTINA KLOIBER
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Blink Health Inc.
Representatives
Robert S. Weisbein FOLEY & LARDNER LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Online retail pharmacy services; Mail order pharmacy services; patient relationship management services
Publications
History of USPTO decisions and trademark events.
34 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/14/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/09/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/07/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/06/2022
IUAA
USE AMENDMENT ACCEPTED
05/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2022
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/08/2022
IUAF
USE AMENDMENT FILED
04/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/07/2022
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/07/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/07/2021
GNFR
FINAL REFUSAL E-MAILED
10/07/2021
CNFR
FINAL REFUSAL WRITTEN
10/07/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
08/17/2021
ALIE
ASSIGNED TO LIE
08/09/2021
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
08/04/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/04/2021
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
08/02/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2021
DRRR
DIVISIONAL REQUEST RECEIVED
06/30/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/30/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/30/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/30/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/30/2020
GNRT
NON-FINAL ACTION E-MAILED
12/30/2020
CNRT
NON-FINAL ACTION WRITTEN
12/30/2020
DOCK
ASSIGNED TO EXAMINER
12/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2020
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
09/17/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/17/2020
NWAP
NEW APPLICATION ENTERED
09/12/2020
Continuous trademark protection
Get notified about every new filing that threatens SCRIPT PARTNER PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.